ABDXF Stock: Abingdon Health Plc Stock Price, Analysis & Insights
Get live abdxf stock price $0.07, comprehensive Abingdon Health Plc stock analysis, charts, news, and expert forecast. Real-time abdxf stock data and investment insights.
Loading chart...
Company Overview
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices worldwide. The company offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; PCRD and PCRD FLEX, nucleic acid lateral flow tests used for rapid readouts post isothermal amplification; Abingdon Simply Test, a range of self-tests; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2. It also provides AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Company Information
- CEO
- Christopher William Hand
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 113
Contact Information
- Address
- York Biotech Campus
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.18) may provide portfolio stability
Business Model & Strategy
Abingdon Health Plc operates in the Medical - Diagnostics & Research industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Christopher William Hand, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Diagnostics & Research model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Abingdon Health Plc competes in the Medical - Diagnostics & Research within the broader Healthcare. With 13.3 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the Other OTC, Abingdon Health Plc provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Abingdon Health Plc should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Abingdon Health Plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Abingdon Health Plc
- ⚠Investors should consider how Abingdon Health Plc fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
13.27M
P/E Ratio
-1.40
Beta
0.18
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 13.27M market capitalization
- Trading Volume: 10.00K shares traded today
- Price Range: 52-week range of $0.07 - $0.07
- Exchange: Listed on Other OTC
Financial Metrics
Market Analysis for Abingdon Health Plc
Abingdon Health Plc (ABDXF) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 13.27M, the company represents a significant player in its market. The stock is currently trading at $0.07 with a positivedaily change of 0.00%.
The company's 113 employee base and presence on the Other OTCexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -1.40, beta of 0.18, and 52-week price range from $0.07 to $0.07when evaluating investment opportunities.
Why Invest in Abingdon Health Plc?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (Other OTC)
- • Experienced leadership under Christopher William Hand
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.